Potential drug-related problems detected by routine pharmaceutical interventions: safety and economic contributions made by hospital pharmacists in Japan

被引:0
|
作者
Tasaka, Yuichi [1 ,2 ]
Tanaka, Akihiro [1 ,2 ,5 ]
Yasunaga, Daiki [1 ,2 ]
Asakawa, Takashige [2 ,3 ]
Araki, Hiroaki [4 ]
Tanaka, Mamoru [1 ,2 ]
机构
[1] Ehime Univ Hosp, Div Pharm, 454 Shitsukawa, Toon, Ehime 7910295, Japan
[2] Ehime Soc Hosp Pharmacists, 454 Shitsukawa, Toon, Ehime 7910295, Japan
[3] Saiseikai Saijo Hosp, Dept Pharm, 269-1 Tsuitachi, Saijo, Ehime 7930027, Japan
[4] Shujitsu Univ, Sch Pharm, Naka Ku, 1-6-1 Nishigawara, Okayama, Okayama 7038516, Japan
[5] Ehime Univ Hosp, Div Pharm, 454 Shitsukawa, Toon, Ehime 7910295, Japan
关键词
Pharmaceutical intervention; Adverse drug reaction; Potential drug-related problem; Elderly patients; Renal dysfunction; Polypharmacy;
D O I
10.1186/s40780-018-0125-z
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BackgroundPharmaceutical intervention enables safe and effective pharmacotherapy by avoiding of adverse drug reactions (ADRs) and efficacy attenuations. Many prescriptions require optimization, and pharmaceutical interventions are inextricably associated with the prevention of potential drug-related problems (DRPs). Although the analysis and understanding of pharmaceutical interventions can lead to improvement in prescription, the analysis of routine pharmaceutical interventions in Japan in insufficient. Thus, we conducted this study to understand potential DRPs by analyzing routine pharmaceutical interventions made by pharmacists in Japan.MethodsPharmacists register the details of pharmaceutical interventions (excluding personal patient information) in a web-based database. We classified data of pharmaceutical interventions into 13 DRP types, 43 DRP subtypes, and 10 intervention categories (e.g., avoidance of serious ADRs and renal dosing recommendations). These data were analyzed with a focus on renal dysfunction and polypharmacy.ResultsDuring the study period, 2376 pharmaceutical interventions were performed. Overall, 68.2% of pharmaceutical interventions were for patients aged over 65years. The most frequently detected potential DRP was overdosage, followed by omission of prescription, contraindications, and duplication of a drug with similar effect. The main cause of contraindication and overdosage was renal function deterioration, and that of polypharmacy was duplication of a drug with similar effect. Using our original evidence-based approach, we found that 2376 pharmaceutical interventions prevented ADRs for 1678 drugs, with potential cost savings of up to USD 2,657,820.ConclusionsOur results indicate that the analysis of routine pharmaceutical interventions is beneficial for detecting potential DRPs. Our findings also show that, in an aging society, pharmacists have an important role in providing medication safety, with potential cost savings.
引用
下载
收藏
页数:11
相关论文
共 50 条
  • [1] Potential drug-related problems detected by routine pharmaceutical interventions: safety and economic contributions made by hospital pharmacists in Japan
    Yuichi Tasaka
    Akihiro Tanaka
    Daiki Yasunaga
    Takashige Asakawa
    Hiroaki Araki
    Mamoru Tanaka
    Journal of Pharmaceutical Health Care and Sciences, 4 (1)
  • [2] Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan
    Tasaka, Yuichi
    Yasunaga, Daiki
    Tanaka, Mamoru
    Tanaka, Akihiro
    Asakawa, Takashige
    Horio, Ikuo
    Miyauchi, Yoshiro
    Araki, Hiroaki
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 321 - 329
  • [3] Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan
    Yuichi Tasaka
    Daiki Yasunaga
    Mamoru Tanaka
    Akihiro Tanaka
    Takashige Asakawa
    Ikuo Horio
    Yoshiro Miyauchi
    Hiroaki Araki
    International Journal of Clinical Pharmacy, 2016, 38 : 321 - 329
  • [4] Study of pharmaceutical interventions and drug-related problems in a general hospital
    Fe Hurtado, Maria
    Barajas, Marta
    Sainz de Rozas, Carlos
    Gallardo, Jara
    Apinaniz, Rebeca
    PHARMACY WORLD & SCIENCE, 2009, 31 (02): : 301 - 301
  • [5] Economic contributions of pharmaceutical interventions by pharmacists: A retrospective report in Japan
    Yasunaga D.
    Tasaka Y.
    Murakami S.
    Tanaka A.
    Tanaka M.
    Araki H.
    Journal of Pharmaceutical Policy and Practice, 10 (1)
  • [6] Evaluation of drug-related problems and subsequent clinical pharmacists' interventions at a Swiss university hospital
    Reinau, Daphne
    Furrer, Chiara
    Staempfli, Dominik
    Bornand, Delia
    Meier, Christoph R.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2019, 44 (06) : 924 - 931
  • [7] Observational study of drug-related problems and clinical pharmacists' interventions in a French paediatric hospital
    Robert, Sophie
    Menetre, Sophie
    Schweitzer, Cyril
    Demore, Beatrice
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2021, 28 (E1) : E85 - E91
  • [8] The Impact Of Clinical Pharmacists' Interventions On Drug-Related Problems At The Military Hospital, Omdurman, Sudan
    Eltaib, Nada Rashad Farrag
    Ahmed, Najla Idriss Abdurhman
    Elnasif, Hala Mahamed
    Abdalla, Ashraf N.
    Alhindi, Yosra
    Elashmony, Sahar
    INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH, 2022, 12 (01): : 88 - 94
  • [9] Analysis of drug-related problems detected in a general hospital
    Najera Perez, Maria Dolores
    Aranda Garcia, Ana
    Calle Urra, Jose Eduardo
    Gomis Cebrian, Rafael
    Iranzo Fernandez, Maria Dolores
    Leon Villar, Josefa
    Ventura Lopez, Maria
    Plaza Aniorte, Joaquin
    REVISTA DE CALIDAD ASISTENCIAL, 2007, 22 (02) : 61 - 66
  • [10] Characteristics of drug-related problems and pharmacists' interventions in a geriatric unit in China
    Ma, Zhuo
    Sun, Shusen
    Zhang, Caixia
    Yuan, Xiangzhi
    Chen, Qing
    Wu, Jinling
    Wang, Xiaojuan
    Liu, Lihong
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (01) : 270 - 274